Table 1.
Clinical characteristics and treatment outcomes of patients
| Case No. | Age/Sex | HbA1c (%) | Duration (months) | BCVA (LogMAR) | Radiological features | Fungal species | Residual Deficits | |
|---|---|---|---|---|---|---|---|---|
| Pre/Post-op | Bone Destruction | Soft Tissue Abnormality | ||||||
| 1* | 66/F | 7.2 | 2 | 2.00/0.15 | Focal erosion | Focal thickening | Aspergillus fumigatus | Resolved |
| 2* | 68/M | 9.4 | 0.25 | 2.90/2.90 | None | None | Rhizopus oryzae | Persistent NLP |
| 3* | 50/M | 5.4 | 1 | 1.82/0.30 | None | Focal thickening | Aspergillus fumigatus | Limited abduction |
| 4 | 33/F | 6.1 | 0.25 | 1.22/0.30 | None | Focal thickening | Penicillium citrinum | Sluggish PLR |
| 5* | 63/F | 8.9 | 2 | 2.30/2.30 | Focal erosion | Focal thickening | Aspergillus fumigatus | Unchanged |
| 6 | 75/M | 5.5 | 36 | 0.15/0.10 | None | Focal thickening | Aspergillus fumigatus | Resolved |
BCVA, best-corrected visual acuity; HbA1c, glycated hemoglobin; LogMAR, logarithm of the minimum angle of resolution; PLR, pupillary light reflex. * Indicates patients with concomitant type 2 diabetes mellitus